Evidence map›Paper›PMID 32274626›Full record

ArticleSurgical endoscopy2020

Could fluorescence-guided surgery be an efficient and sustainable option? A SICE (Italian Society of Endoscopic Surgery) health technology assessment summary.

N Vettoretto, E Foglia, L Ferrario, C Gerardi, B Molteni, U Nocco, E Lettieri, S Molfino, G L Baiocchi, U Elmore and 14 more

Open access · bronzeAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Indocyanine green: The guide to safer and more effective surgery.World journal of gastrointestinal surgery · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 18 institutions in 1 country.

N VettorettoChirurgia Montichiari, Azienda Socio Sanitaria Territoriale Degli Spedali Civili, V.le Ciotti 154, Montichiari, 25018, Brescia, Italy. nereovet@gmail.com.
E FogliaLIUC - Università Cattaneo, Castellanza, VA, Italy.
L FerrarioLIUC - Università Cattaneo, Castellanza, VA, Italy.
C GerardiCentro di Politiche Regolatorie, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.
B MolteniDepartment of Clinical and Experimental Surgery, University of Brescia, Brescia, Italy.
U NoccoIngegneria Clinica, Azienda Socio Sanitaria Territoriale dei Sette Laghi, Varese, Italy.
E LettieriSchool of Management, Department of Management, Economics and Industrial Engineering, Politecnico, Milano, Italy.
S MolfinoDepartment of Clinical and Experimental Surgery, University of Brescia, Brescia, Italy.
G L BaiocchiDepartment of Clinical and Experimental Surgery, University of Brescia, Brescia, Italy.
U ElmoreDepartment of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
R RosatiDepartment of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
G CurròDepartment of Human Pathology of Adult and Evolutive Age, University Hospital of Messina, Messina, Italy.
E CassinottiChirurgia Generale, Fondazione IRCCS - Ca' Granda - Ospedale Maggiore Policlinico - University of Milan, Milan, Italy.
L BoniChirurgia Generale, Fondazione IRCCS - Ca' Granda - Ospedale Maggiore Policlinico - University of Milan, Milan, Italy.
R CirocchiDepartment of Surgical Sciences, University of Perugia, Perugia, Italy.
A MaranoChirurgia Generale ed Oncologica, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
W L PetzChirurgia, IEO, European Institute of Oncology IRCCS, Milan, Italy.
A ArezzoDepartment of Surgical Sciences, University of Torino, Turin, Italy.
M A BoninoDepartment of Surgical Sciences, University of Torino, Turin, Italy.
F DaviniCentro multidisciplinare Chirurgia Robotica, Chirurgia Toracica mini-invasiva e Robotica, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
A BiondiChirurgia Generale, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
G AnaniaChirurgia Generale, University of Ferrara, Ferrara, Italy.
F AgrestaChirurgia Generale, Azienda ULSS 5 "Polesana", Hospital of Adria, Adria, RO, Italy.
G SilecchiaDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome-Polo Pontino, Rome, Italy.
University of Brescia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity Carlo Cattaneo · ITUniversity of Turin · ITAgostino Gemelli University Polyclinic · ITAzienda Ospedaliera Universitaria Pisana · ITAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITAzienda Socio Sanitaria Territoriale Lariana · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMario Negri Institute for Pharmacological Research · ITPolitecnico di Milano · ITSapienza University of Rome · ITUniversity of Ferrara · ITUniversity of Messina · ITUniversity of Milan · ITUniversity of Perugia · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndocyanine green fluorescence vision is an upcoming technology in surgery. It can be used in three ways: angiographic and biliary tree visualization and lymphatic spreading studies. The present paper shows the most outstanding results from an health technology assessment study design, conducted on fluorescence-guided compared with standard vision surgery.

methodsA health technology assessment approach was implemented to investigate the economic, social, ethical, and organizational implications related to the adoption of the innovative fluorescence-guided view, with a focus on minimally invasive approach. With the support of a multidisciplinary team, qualitative and quantitative data were collected, by means of literature evidence, validated questionnaires and self-reported interviews, considering the dimensions resulting from the EUnetHTA Core Model.

resultsFrom a systematic search of literature, we retrieved the following studies: 6 on hepatic, 1 on pancreatic, 4 on biliary, 2 on bariatric, 4 on endocrine, 2 on thoracic, 11 on colorectal, 7 on urology, 11 on gynecology, 2 on gastric surgery. Fluorescence guide has shown advantages on the length of hospitalization particularly in colorectal surgery, with a reduction of the rate of leakages and re-do anastomoses, in spite of a slight increase in operating time, and is confirmed to be a safe, efficacious, and sustainable vision technology. Clinical applications are still presenting a low evidence in the literature.

conclusionThe present paper, under the patronage of Italian Society of Endoscopic Surgery, based on an HTA approach, sustains the use of fluorescence-guided vision in minimally invasive surgery, in the fields of general, gynecologic, urologic, and thoracic surgery, as an efficient and economically sustainable technology.

Indexed as

Efficiency, OrganizationalFluorescenceIndocyanine GreenSustainable DevelopmentEndoscopyHumansItalyOperative TimeQualitative ResearchSocieties, MedicalSurgery, Computer-AssistedSystematic Reviews as TopicTechnology Assessment, BiomedicalIndocyanine GreenFluorescenceIndocyanine greenLaparoscopySurgery

Identifiers

PMID32274626
OpenAlexW3015924156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.